Our study uncovers that mucinous CRC may serve as comfortable niche for inhibitor of apoptosis proteins such as BIRC7/Livin to strive and facilitate treatment resistance, local recurrence and metastasis especially after neoadjuvant chemotherapy with FOLFOX. This evidence concerns the gene BIRC7 and colorectal carcinoma.